Hooman Hakami

Group President, Diabetes
Medtronic plc

Hooman Hakami is executive vice president and group president of Medtronic Diabetes, the world leader in advanced diabetes management. With $1.7 billion in 2014 revenue, diabetes is Medtronic’s fifth largest business unit.

Hakami joined Medtronic in June 2014 after more than 20 years at General Electric. He was president and chief executive officer of detection and guidance solutions at GE Healthcare from April 2012 until May 2014. In that role, he led that company’s business, specializing in x-ray based technology solutions.

During Hakami’s tenure, he has overseen the acquisition of Diabeter and launched a partnership with IBM Watson to develop a new generation of personalized diabetes management solutions.